Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E21.78 EPS (ttm)6.03 Insider Own0.07% Shs Outstand2.65B Perf Week-0.51%
Market Cap348.43B Forward P/E14.38 EPS next Y9.13 Insider Trans0.17% Shs Float2.64B Perf Month-0.54%
Income16.33B PEG3.23 EPS next Q2.01 Inst Own70.00% Short Float0.60% Perf Quarter-5.23%
Sales81.33B P/S4.28 EPS this Y7.60% Inst Trans0.19% Short Ratio2.12 Perf Half Y-3.68%
Book/sh22.92 P/B5.73 EPS next Y6.15% ROA10.60% Target Price149.35 Perf Year0.71%
Cash/sh5.76 P/C22.81 EPS next 5Y6.74% ROE26.80% 52W Range121.00 - 148.99 Perf YTD1.79%
Dividend3.80 P/FCF40.36 EPS past 5Y3.10% ROI17.00% 52W High-11.14% Beta0.66
Dividend %2.89% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.80% 52W Low9.41% ATR2.07
Employees135100 Current Ratio1.30 Sales Q/Q-1.30% Oper. Margin23.40% RSI (14)48.63 Volatility1.35% 1.40%
OptionableYes Debt/Eq0.48 EPS Q/Q43.40% Profit Margin20.10% Rel Volume0.35 Prev Close131.36
ShortableYes LT Debt/Eq0.46 EarningsJul 16 BMO Payout59.60% Avg Volume7.45M Price132.39
Recom2.30 SMA201.13% SMA50-2.55% SMA200-3.08% Volume585,877 Change0.79%
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Aug-18-19 03:11PM  What Do AA+ and AAA Credit Ratings Mean? Investopedia
Aug-17-19 11:27AM  Top Defensive Consumer Stocks for 2018 Investopedia
Aug-16-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION UPDATE by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson - JNJ Business Wire
12:36PM  Jabil Inc. -- Moody's assigns Prime-3 short term rating to Jabil's new $1.8 billion commercial paper program Moody's
11:28AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY Zacks
09:55AM  10 Best Stocks to Buy and Hold Forever InvestorPlace
09:39AM  These are the largest companies in each U.S. state Yahoo Finance
Aug-15-19 03:36PM  The Top Pharma Stocks for 2019 Investopedia
09:30AM  Why Is Johnson & Johnson (JNJ) Down 1.2% Since Last Earnings Report? Zacks
Aug-14-19 09:24AM  Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study Zacks
07:10AM  JNJ Stock Is a Way Better Investment Than Bonds or CDs InvestorPlace
Aug-13-19 11:40AM  Lilly's Psoriasis Drug Found Superior To J&J's Tremfya In Phase 4 Study Benzinga
07:15AM  What Kind Of Shareholders Own Johnson & Johnson (NYSE:JNJ)? Simply Wall St.
06:00AM  5 Biggest New Drugs Approved in 2019 So Far Motley Fool
Aug-12-19 01:54PM  Dow Jones Falls 300 Points; Pfizer, Goldman Sachs Lead Downside Investor's Business Daily
12:50PM  The 10 Biggest Value Stocks Motley Fool
09:30AM  J&J's Tuberculosis Drug Gets FDA Nod for Adolescent Patients Zacks
09:15AM  Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio Zacks
Aug-10-19 12:04PM  3 Top Dividend Aristocrats to Buy Now Motley Fool
Aug-09-19 11:02AM  Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates Zacks
09:00AM  Johnson & Johnson Is A Massive Pharma Stock But Should You Buy It? Investor's Business Daily
Aug-08-19 02:42PM  Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference PR Newswire
02:32PM  Johnson & Johnson to Participate in the Wells Fargo Securities 2019 Healthcare Conference PR Newswire
11:06AM  Perrigo (PRGO) Beats on Q2 Earnings and Sales, Stock Up Zacks
08:01AM  Yield Growth Corp Provides Mid-Year 2019 Corporate Update GlobeNewswire
Aug-07-19 08:34AM  4 Defensive Stocks to Weather Trade-War Volatility TipRanks
Aug-06-19 08:00PM  3 Stocks You Can Set and Forget Motley Fool
01:02PM  The Opioid Crisis Cant Be Engineered Away Bloomberg
06:00AM  What You'll Want to Know About Arrowhead Pharmaceuticals' Q3 Update Motley Fool
Aug-04-19 09:23AM  [video]Johnson & Johnson says Jury Rules in its Favor in Cancer Case TheStreet.com
09:00AM  These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024 Motley Fool
Aug-02-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION UPDATE BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson - JNJ PR Newswire
10:48AM  Geron (GERN) Stock Up Despite Q2 Earnings & Sales Miss Zacks
06:00AM  What You'll Want to Know About Geron's Q2 Results Motley Fool
Aug-01-19 03:37PM  Theravance (TBPH) Q2 Loss Narrower, Revenues Beat Estimates Zacks
Jul-31-19 06:38PM  Oklahoma makes final bid to hold J&J responsible for opioid epidemic Reuters
06:35PM  REFILE-Oklahoma makes final bid to hold J&J responsible for opioid epidemic Reuters
01:24AM  Veracyte (VCYT) Q2 2019 Earnings Call Transcript Motley Fool
Jul-30-19 01:14PM  Merck Shares Rise on Strong Sales Growth GuruFocus.com
12:49PM  Merck (MRK) Beats on Q2 Earnings & Sales, Raises '19 View Zacks
12:22PM  FTC investigating Johnson & Johnson's Remicade contracting practices American City Business Journals
11:29AM  Gains in Knee Replacement Driving Zimmer Biomet Growth GuruFocus.com
07:03AM  9 Best Dividend Stocks to Buy for Every Investor InvestorPlace
Jul-29-19 06:04PM  US Indexes Close Mostly Lower on Monday GuruFocus.com
05:55PM  UPDATE 2-J&J says FTC probing efforts to protect arthritis drug Remicade Reuters
05:24PM  J&J says FTC probing efforts to protect arthritis drug Remicade Reuters
04:58PM  J&J says FTC probing efforts to protect arthritis drug Remicade Reuters
03:52PM  5 Top Stock Trades for Tuesday: SHOP, NFLX, JNJ InvestorPlace
03:49PM  Dow Jones Edges Higher on Monday GuruFocus.com
03:05PM  Pfizer to Combine Off-Patent Drug Business With Mylan GuruFocus.com
09:27AM  3 Healthcare Stocks With Rising Expectations Motley Fool
08:26AM  Why Johnson & Johnson Stock Isnt a Buy Yet InvestorPlace
Jul-28-19 04:36PM  KBL Merger Corp Acquires Cannabis-Focused Biotech Company Benzinga
Jul-27-19 12:20PM  10 Biggest Cancer-Fighting Stocks Motley Fool
12:17PM  10 Biggest Medical Device Stocks Motley Fool
Jul-26-19 11:57AM  AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View Zacks
11:22AM  Senate advances bill to cut the cost of prescriptions Yahoo Finance Video
09:17AM  Is the Colombian Cannabis Industry Leading Latin America, Or Just Leading Investors On A Wild Goose Chase? Motley Fool
07:26AM  The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint Benzinga
02:00AM  Drugmakers: Our Take on Earnings Morningstar
Jul-25-19 09:59AM  UPDATE 2-Deployment of second Ebola vaccine would not be quick fix, experts warn Reuters
09:59AM  Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong Zacks
09:15AM  Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Zacks
07:38AM  What Are Analysts Saying About The Future Of Johnson & Johnson's (NYSE:JNJ)? Simply Wall St.
07:33AM  Deployment of second Ebola vaccine would not be quick fix, experts warn Reuters
Jul-24-19 09:51AM  Is Johnson & Johnson Stock Losing Its Shine? InvestorPlace
Jul-23-19 04:00PM  How to Invest in Cancer-Fighting Stocks Motley Fool
10:16AM  Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View Zacks
08:13AM  Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings? Zacks
06:06AM  3 of the Most Rock-Solid Dividend Stocks in the World Motley Fool
04:37AM  Drugmakers shell out record amount lobbying Congress Financial Times
Jul-22-19 01:03PM  The 10 Biggest Blue Chip Stocks Motley Fool
12:56PM  J&J in hot water after safety lawsuits over baby powder Yahoo Finance Video
11:44AM  Johnson & Johnson faces more than 14k lawsuits over talc products Yahoo Finance Video
11:43AM  The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM Zacks
10:52AM  Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal Yahoo Finance
10:43AM  Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal Yahoo Finance Video
10:30AM  UPDATE 3-Congo minister's resignation over Ebola snub could unblock new vaccine Reuters
09:55AM  Is a Beat in Store for AbbVie (ABBV) This Earnings Season? Zacks
09:15AM  Stocks Slip This Week on Earnings, Fed Uncertainties Zacks
07:00AM  Is Johnson & Johnson a Buy? Motley Fool
Jul-21-19 06:09PM  Do you want to be CEO? Women face these extra obstacles on their way to the C-suite MarketWatch
02:15PM  Benzinga's Bulls And Bears: Apple, Boeing, Disney, Johnson & Johnson And More Benzinga
Jul-19-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION UPDATE by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson - JNJ Business Wire
05:00PM  Edited Transcript of JNJ earnings conference call or presentation 16-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
11:06AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific Zacks
10:23AM  Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts Benzinga
09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
08:56AM  Dow 30 Stock Roundup: MSFT, JPM, IBM, JNJ, GS Earnings Impress Zacks
Jul-18-19 05:23PM  3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement Zacks
03:01PM  Jim Cramer: Looking for Netflix Action? Don't Be a Hero TheStreet.com
01:33PM  Top Stock Reports for Johnson & Johnson, NextEra & Deere Zacks
09:41AM  5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report Motley Fool
Jul-17-19 04:19PM  These 4 Medical Stocks Could Benefit From J&J Earnings Here's Why Investor's Business Daily
01:33PM  FlexShares Makes A Big Low Vol ETF Splash Benzinga
01:24PM  After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk Benzinga
10:50AM  Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat Zacks
09:30AM  Company News for Jul 17, 2019 Zacks
03:49AM  WHO declares emergency over Ebola epidemic in Congo Financial Times
Jul-16-19 11:45PM  Opioid makers dumped 76 billion pills onto U.S. market over 7 critical years, data shows MarketWatch
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM